Patent application number | Description | Published |
20130064880 | ADMINISTRATION REGIME FOR N-HYDROXY-4-BENZAMIDE - N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}-benzamide of formula (I): | 03-14-2013 |
20140341989 | FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND USES THEREOF - Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include bendamustine, or a pharmaceutically acceptable salt thereof and an HDAC inhibitor, or a pharmaceutically acceptable salt thereof, are described. | 11-20-2014 |
20150024040 | ADMINISTRATION REGIME FOR N-HYDROXY-4-BENZAMIDE - N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}-benzamide of formula (I): | 01-22-2015 |
20150038513 | ASSOCIATION BETWEEN N-HYDROXY-4-BENZAMIDE AND FOLFOX - Association between N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-yl-carbonylamino]ethoxy}benzamide of formula (I): | 02-05-2015 |
20150051189 | INDOLIZINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Compounds of formula (I): | 02-19-2015 |